Target intelligence / Profile preview

Family with sequence similarity 24 member B (FAM24B)

Target
FAM24B
Molecular classification
Other (predicted secreted modulator; not classified as receptor, enzyme, transporter, ion channel, or transcription factor)
01

Overview

Family with sequence similarity 24 member B (FAM24B) is a human protein encoded by a protein-coding gene located on chromosome 10. It is primarily found in the extracellular region and is predicted to act as a local modulator of key ion transporters, such as V-ATPase and CFTR, often enhancing or inhibiting their activities[3][9][13]. Its protein domain and biological pathway annotations remain limited, and its molecular functions are not fully identified[10]. FAM24B is considered a potential prognostic biomarker in certain cancers due to its methylation and gene expression patterns, but is not currently recognized as a typical drug target, nor does it have well-established therapeutic or receptor-like roles[5][2]. Detection of FAM24B or its methylation status may assist in prognosis or cancer subtype classification, although clinical utility has yet to be systematically established.

Other names
Protein FAM24BMGC45962AC073585.2FAM24BFA24BHGNC:23475NCBI Gene:196792Ensembl: ENSG00000213185UniProtKB: Q8N5W8
02

Mechanism of action

None (no drugs are known to target FAM24B, and molecular mechanism remains to be defined)

03

Biological functions

Protein binding (Gene Ontology annotation), but detailed mechanism remains unknownModulation of ion transporters (predicted)May function as a transcriptional repressor (uncertain, based on fusion gene evidence, not direct annotation)Other (actual roles remain to be confirmed)
04

Disease associations

Cancer (prognostic biomarker in esophageal cancer and implicated in breast cancer subtype gene expression signatures)Other (requires more validation in disease contexts)
05

Safety considerations

None reported (no known therapeutic challenges for targeting FAM24B as of current knowledge)
06

Interacting drugs

None (no established drug interactions reported in available literature or databases)
07

Biomarkers

DNA methylation and expression of FAM24B as a part of a two-gene risk signature for predicting survival in esophageal cancerPart of breast cancer molecular subtype gene expression signatures (potential use in subtype classification, not in direct patient selection for therapy)

Beyond the preview

Go deeper on Family with sequence similarity 24 member B (FAM24B).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Family with sequence similarity 24 member B (FAM24B).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call